265 related articles for article (PubMed ID: 8478856)
1. Treatment of systemic lupus erythematosus by prolonged administration of high dose intravenous immunoglobulin: report of 2 cases.
Winder A; Molad Y; Ostfeld I; Kenet G; Pinkhas J; Sidi Y
J Rheumatol; 1993 Mar; 20(3):495-8. PubMed ID: 8478856
[TBL] [Abstract][Full Text] [Related]
2. High-dose intravenous immunoglobulins: an option in the treatment of systemic lupus erythematosus.
Toubi E; Kessel A; Shoenfeld Y
Hum Immunol; 2005 Apr; 66(4):395-402. PubMed ID: 15866703
[TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulin for immunomodulation of systemic lupus erythematosus.
Sherer Y; Shoenfeld Y
Autoimmun Rev; 2006 Feb; 5(2):153-5. PubMed ID: 16431350
[TBL] [Abstract][Full Text] [Related]
4. [Long-term treatment with i.v. immunoglobulin in the therapy of systemic lupus erythematosus].
Francioni C; Fioravanti A; Gelli R; Megale F; Marcolongo R
Recenti Prog Med; 1993 Oct; 84(10):679-86. PubMed ID: 8235034
[TBL] [Abstract][Full Text] [Related]
5. Low dose intravenous immunoglobulin in systemic lupus erythematosus: analysis of 62 cases.
Sherer Y; Kuechler S; Jose Scali J; Rovensky J; Levy Y; Zandman-Goddard G; Shoenfeld Y
Isr Med Assoc J; 2008 Jan; 10(1):55-7. PubMed ID: 18300575
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside.
Zandman-Goddard G; Blank M; Shoenfeld Y
Lupus; 2009 Sep; 18(10):884-8. PubMed ID: 19671787
[TBL] [Abstract][Full Text] [Related]
7. [Intravenous administration of immunoglobulins in systemic lupus erythematosus: review of the literature and initial clinical experiences].
Pirner K; Rubbert A; Burmester GR; Kalden JR; Manger B
Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():131-5; discussion 136. PubMed ID: 8499742
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of systemic lupus erythematosus with intravenous human immunoglobulins. Preliminary study].
Migliaresi S; Gallo M; Tirri G
Clin Ter; 1992 Sep; 141(9 Pt 2):83-4. PubMed ID: 1468203
[TBL] [Abstract][Full Text] [Related]
9. A case of Evans syndrome combined with systemic lupus erythematosus successfully treated with rituximab.
Kittaka K; Dobashi H; Baba N; Iseki K; Kameda T; Susaki K; Kitanaka A; Kubota Y; Ishida T
Scand J Rheumatol; 2008; 37(5):390-3. PubMed ID: 18609263
[TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulin therapy and systemic lupus erythematosus.
Zandman-Goddard G; Levy Y; Shoenfeld Y
Clin Rev Allergy Immunol; 2005 Dec; 29(3):219-28. PubMed ID: 16391397
[TBL] [Abstract][Full Text] [Related]
11. [High dose intravenous immunoglobulins in treating systemic lupus erythematosus-associated thrombocytopenia].
Zhang X; Dong Y; Tang F; Zhang F; Li H
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):82-4. PubMed ID: 12903501
[TBL] [Abstract][Full Text] [Related]
12. Steroid sparing effect of intravenous immunoglobulin therapy in patients with pemphigus foliaceus.
Sami N; Qureshi A; Ahmed AR
Eur J Dermatol; 2002; 12(2):174-8. PubMed ID: 11872417
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion.
Perricone R; De Carolis C; Kröegler B; Greco E; Giacomelli R; Cipriani P; Fontana L; Perricone C
Rheumatology (Oxford); 2008 May; 47(5):646-51. PubMed ID: 18346976
[TBL] [Abstract][Full Text] [Related]
14. High dose intravenous immunoglobulins in systemic lupus erythematosus: clinical and serological results of a pilot study.
Schroeder JO; Zeuner RA; Euler HH; Löffler H
J Rheumatol; 1996 Jan; 23(1):71-5. PubMed ID: 8838511
[TBL] [Abstract][Full Text] [Related]
15. Sugar-free, glycine-stabilized intravenous immunoglobulin prevents skin but not renal disease in the MRL/lpr mouse model of systemic lupus.
Racz Z; Nagy E; Rosivall L; Szebeni J; Hamar P
Lupus; 2010 Apr; 19(5):599-612. PubMed ID: 20167630
[TBL] [Abstract][Full Text] [Related]
16. [Cyclosporin therapy of patients with systemic lupus erythematosus].
Gergely P
Orv Hetil; 1994 Nov; 135(47):2591-5. PubMed ID: 7824258
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment with intravenous immunoglobulins in a patient affected by dermatomyositis/systemic lupus erythematosus overlap syndrome and tuberculosis.
Luzi G; Diamanti AP; Germano V; Laganà B; Di Rosa R; Salemi S; Stoppacciaro A; D'Amelio R
Clin Immunol; 2007 Nov; 125(2):127-30. PubMed ID: 17720626
[TBL] [Abstract][Full Text] [Related]
18. Intravenous immunoglobulin (IVIg) for therapy-resistant cutaneous lupus erythematosus (LE).
Goodfield M; Davison K; Bowden K
J Dermatolog Treat; 2004 Jan; 15(1):46-50. PubMed ID: 14754650
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone cyclophosphamide pulse therapy in systemic lupus erythematosus: a case report.
Gupta R; Gupta S; Khera V
J Dermatolog Treat; 2009; 20(1):55-8. PubMed ID: 18618362
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin therapy for patients with bullous pemphigoid unresponsive to conventional immunosuppressive treatment.
Ahmed AR
J Am Acad Dermatol; 2001 Dec; 45(6):825-35. PubMed ID: 11712025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
